Cover Image

On Assessing Overall Survival (OS) in Oncology Studies

Fuente: arXiv

Saved in:

Bibliographic Details
Main Author:	Hsu, Jason C.
Format:	Preprint
Published:	2025
Subjects:	Methodology Applications
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Nonparametric Bayesian Multi-Treatment Mixture Cure Survival Model with Application in Pediatric Oncology
by: Chang, Peter, et al.
Published: (2025)

Distribution-Free Selection of Low-Risk Oncology Patients for Survival Beyond a Time Horizon
by: Sesia, Matteo, et al.
Published: (2025)

A Functional Approach to Testing Overall Effect of Interaction Between DNA Methylation and SNPs
by: Gansou, Yvelin, et al.
Published: (2025)

Index Date Imputation For Survival Outcomes for Externally Controlled Trials
by: Coent, Q. Le, et al.
Published: (2025)

Weighted Brier Score -- an Overall Summary Measure for Risk Prediction Models with Clinical Utility Consideration
by: Zhu, Kehao, et al.
Published: (2024)

Cost-Effectiveness Analysis for Disease Prevention -- A Case Study on Colorectal Cancer Screening
by: Xiong, Yi, et al.
Published: (2024)

Assessing treatment efficacy for interval-censored endpoints using multistate semi-Markov models fit to multiple data streams
by: Morsomme, Raphael, et al.
Published: (2025)

Evaluating causal effects on time-to-event outcomes in an RCT in Oncology with treatment discontinuation
by: Ballerini, Veronica, et al.
Published: (2023)

Assessing Vaccine Effectiveness in Observational Studies via Nested Trial Emulation
by: DeMonte, Justin B., et al.
Published: (2024)

Precision Dose-Finding Design for Phase I Oncology Trials by Integrating Pharmacology Data
by: Lee, Kyong Ju, et al.
Published: (2025)

A Seamless Phase II/III Design with Dose Optimization for Oncology Drug Development
by: Li, Yuhan, et al.
Published: (2024)

BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials
by: Chen, Yuxuan, et al.
Published: (2026)

Semiparametric Piecewise Accelerated Failure Time Model for the Analysis of Immune-Oncology Clinical Trials
by: Sunami, Hisato, et al.
Published: (2024)

Network Meta Analysis of Mean Survival
by: Apsemidis, Anastasios, et al.
Published: (2025)

Multiple Testing of Partial Conjunction Hypotheses for Assessing Replicability Across Dependent Studies
by: Dey, Monitirtha, et al.
Published: (2025)

Stable Survival Extrapolation via Transfer Learning
by: Apsemidis, Anastasios, et al.
Published: (2024)

Mediation Analysis for Sparse and Irregularly Spaced Longitudinal Outcomes with Application to the MrOS Sleep Study
by: Ren, Rui, et al.
Published: (2025)

Random Effect Restricted Mean Survival Time Model
by: Hanada, Keisuke, et al.
Published: (2024)

Multicalibration for Modeling Censored Survival Data with Universal Adaptability
by: Ye, Hanxuan, et al.
Published: (2024)

Defining Utility as a Measure of Preference Under Uncertainty in Phase I-II Oncology Dose Finding Trials
by: Hall, Andrew, et al.
Published: (2025)

Pseudo P-values for Assessing Covariate Balance in a Finite Study Population with Application to the California Sugar Sweetened Beverage Tax Study
by: Han, Bing, et al.
Published: (2024)

Weighted Conformal Prediction for Survival Analysis under Covariate Shift
by: Shin, Jaeyoung, et al.
Published: (2025)

Inference on Survival Reliability with Type-I Censored Weibull data
by: Liu, Bowen, et al.
Published: (2026)

Assessing the Impact of Covariate Distribution and Positivity Violation on Weighting-Based Indirect Comparisons: a Simulation Study
by: Serret-Larmande, Arnaud, et al.
Published: (2025)

Estimating Interpretable Heterogeneous Treatment Effect with Causal Subgroup Discovery in Survival Outcomes
by: Bo, Na, et al.
Published: (2024)

Flexible Estimation of the Heterogeneous Non-Parametric Component in a Relative Survival Cure Model
by: Di Mari, Fabrizio, et al.
Published: (2025)

Dynamic Prediction of the Target Survival Time in Metastatic Solid Tumor Cancer Clinical Trials
by: Wang, Sidi, et al.
Published: (2026)

Surviving the frailty of time to event analysis in massive datasets with Generalized Additive Models (and the help of Simon Laplace)
by: Argyropoulos, Christos, et al.
Published: (2025)

Using Individualized Treatment Effects to Assess Treatment Effect Heterogeneity
by: Sechidis, Konstantinos, et al.
Published: (2025)

Bayesian Variable Selection in Distributed Lag Models: A Focus on Binary Quantile and Count Data Regressions
by: Dempsey, Daniel, et al.
Published: (2024)

Assessing variable importance in survival analysis using machine learning
by: Wolock, Charles J., et al.
Published: (2023)

Bayesian Joint Modeling of Zero-Inflated Longitudinal Data and Survival with a Cure Fraction: Application to AIDS Data
by: Baghfalaki, Taban, et al.
Published: (2025)

Bootstrap-Aggregated Method-of-Moments Estimation of the Copula Correlation Parameter for Marginal Survival Inference under Dependent Censoring
by: Zhang, Hyun-Soo, et al.
Published: (2026)

A Bayesian theory for estimation of biodiversity
by: Rigon, Tommaso, et al.
Published: (2025)

Assessing the Accuracy of Multisource Register-based Official Statistics for Multinomial Outcomes
by: Deliu, Nina, et al.
Published: (2025)

Comparing Lasso and Adaptive Lasso in High-Dimensional Data: A Genetic Survival Analysis in Triple-Negative Breast Cancer
by: González-Barquero, Pilar, et al.
Published: (2024)

Assessing Heterogeneity of Treatment Effects
by: Kaji, Tetsuya, et al.
Published: (2023)

Time-Dependent Pseudo $\boldsymbol{R^2}$ for Assessing Predictive Performance in Competing Risks Data
by: Zhuang, Zian, et al.
Published: (2025)

Assessing Climate-Driven Mortality Risk: A Stochastic Approach with Distributed Lag Non-Linear Models
by: Min, Jiacheng, et al.
Published: (2025)

Spatiotemporal causal inference with arbitrary spillover and carryover effects: Airstrikes and insurgent violence in the Iraq War
by: Mukaigawara, Mitsuru, et al.
Published: (2025)